Steady-State Pharmacokinetics and Tolerability of Indinavir-Lopinavir/R Combination Therapy in Antiretroviral-Experienced Patients
暂无分享,去创建一个
[1] P. Cane,et al. Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen. , 2004, The Journal of antimicrobial chemotherapy.
[2] D. Breilh,et al. Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR Study) , 2004, AIDS.
[3] F. Clavel,et al. Interactions Between Amprenavir and the Lopinavir‐ritonavir Combination in Heavily Pretreated Patients Infected with Human Immunodeficiency Virus , 2004, Clinical pharmacology and therapeutics.
[4] R. Aarnoutse,et al. High-performance liquid chromatography of HIV protease inhibitors in human biological matrices. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[5] Thomas Layloff,et al. Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.
[6] J. Beijnen,et al. Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs , 2004, Clinical pharmacokinetics.